跳至主要内容
临床试验/NCT05807984
NCT05807984尚未招募2 期

A Prospective Phase II Clinical Study of Carbon Ion Re-irradiation in Unresectable Locally Recurrent Rectal Cancer

Xin Cai1 个研究点 分布在 1 个国家目标入组 31 人开始时间: 2023年5月1日最近更新:
适应症

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
31
试验地点
1
主要终点
local control

研究概览

简要总结

Prospective phase II clinical study aim to explore the clinical outcome of patients with unresectable locally recurrent rectal cancer (LRRC) treated with re-irradiation by carbon ion radiotherapy (CIRT)

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • pathologically confirmed rectal adenocarcinoma (including mucinous adenocarcinoma and signet-ring cell carcinoma) and LRRC confirmed by biopsy or clinical diagnosis,
  • received a radical operation for their primary tumor and regional lymph nodes,
  • received chemo-radiation or radiation in pelvic before CIRT,
  • received re-irradiation by CIRT after their pelvic radiotherapy.

排除标准

  • received more than once prior radiotherapy in the same treatment field,
  • time to the last radiotherapy was <1 year,
  • space between the lesion to organ at risk (OARs) (bladder or digestive tract) was too close (<5 mm).

结局指标

主要结局

local control

时间窗: Local control at 3 years after CIRT

local control rate of the lesion treated by CIRT

次要结局

  • progression free survival(3 years after CIRT or patient died, measured erery 3 months after CIRT)
  • overall survival(3 years after CIRT or patient died, measured erery 3 months after CIRT)

研究者

发起方
Xin Cai
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Xin Cai

Deputy chief physician

Shanghai Proton and Heavy Ion Center

研究点 (1)

Loading locations...

相似试验